ENDRA Life Sciences (NDRA) Share-based Compensation (2016 - 2021)
Historic Share-based Compensation for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to $411737.0.
- ENDRA Life Sciences' Share-based Compensation fell 2419.04% to $411737.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.4 million, marking a year-over-year decrease of 3128.78%. This contributed to the annual value of $571924.0 for FY2024, which is 4260.27% down from last year.
- Latest data reveals that ENDRA Life Sciences reported Share-based Compensation of $411737.0 as of Q4 2021, which was down 2419.04% from $327799.0 recorded in Q3 2021.
- ENDRA Life Sciences' Share-based Compensation's 5-year high stood at $546040.0 during Q2 2020, with a 5-year trough of $29698.0 in Q1 2017.
- For the 5-year period, ENDRA Life Sciences' Share-based Compensation averaged around $365859.5, with its median value being $365571.5 (2018).
- Over the last 5 years, ENDRA Life Sciences' Share-based Compensation had its largest YoY gain of 297206.67% in 2017, and its largest YoY loss of 6204.24% in 2017.
- Over the past 5 years, ENDRA Life Sciences' Share-based Compensation (Quarter) stood at $402443.0 in 2017, then dropped by 23.53% to $307750.0 in 2018, then grew by 23.23% to $379247.0 in 2019, then skyrocketed by 43.21% to $543120.0 in 2020, then fell by 24.19% to $411737.0 in 2021.
- Its last three reported values are $411737.0 in Q4 2021, $327799.0 for Q3 2021, and $383087.0 during Q2 2021.